Gamida Cell Ltd 's ROA from the first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Gamida Cell Ltd 's ROA in the first quarter of 2024?
Gamida Cell Ltd recorded a cumulative net loss of $-19 million during 12 months ending in the first quarter of 2024, resulting in a negative return on assets (ROA) of -12.89%.

However, within the Healthcare sector Gamida Cell Ltd achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the fourth quarter of 2023 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Total Assets Change	-48.31 %	-61.79 %	-29.61 %	-36.49 %	-10.82 %
Y / Y Net Income Change	-	-	-91.47 %	-	-
Net Income (TTM) in million	-19	-60	-74	-58	-7
Return On Assets (TTM)	-12.89 %	-34.03 %	-31.81 %	-23.04 %	-2.71 %
GMDA's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	122	139	169	162	235
Seq. Total Assets Change	-12.43 %	-17.89 %	4.63 %	-31.3 %	-35.27 %
Seq. Net Income Change	-	-	-	-	-

GMDA's 5 Years Annual ROA >> Back to GMDA Management Effectiveness >> Compare GMDA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Gamida Cell Ltd 's Assets	$ 122 million	GMDA's Balance sheet
Gamida Cell Ltd 's Income	$ 20 million	Quarterly GMDA's Income Statement
GMDA's Income by Division		See GMDA's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	-52.55 %	19.41 %	-15.2 %	451.85 %	13.38 %
Total Assets in million	139	293	245	289	52
Y / Y Net Income Change	-20.63 %	-	-	-	-
Net Income in million	63	79	-90	-62	-34
Annual Return On Assets	45.37 %	27.12 %	-36.64 %	-21.31 %	-65.6 %

GMDA's 5 Years Annual ROA >> Back to GMDA Management Effectiveness >> Compare GMDA ROA to its Competitors

Comment on GMDA's ROA in the fiscal year ending 2023

Despite deterioration in net income of -20.63 % to $63.00 million, Gamida Cell Ltd 's ROA improved in the fiscal year2023 to 45.37 % compared to previous year, as the value of GMDA's assets decline even faster to $138.85 million, from $138.85 a year before.

More Return On Assets Ratios
GMDA's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GMDA's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GMDA's Competitors
Subscribers only: Roa for Gamida Cell Ltd 's Suppliers
Subscribers only: Return On Assets for GMDA's Customers

You may also want to know
GMDA's Roi	GMDA's Inventory Turnover Ratio	GMDA's Growth Rates	GMDA's Dividend Comparisons
	GMDA's Profitability Ratios	GMDA's Asset Turnover Ratio	GMDA's Dividend Growth
GMDA's Roe	GMDA's Valuation Ratios	GMDA's Financial Strength Ratios	GMDA's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2024, within Healthcare Sector

ROA

Date modified: 2026-06-23T19:22:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.